Human Genome Epidemiology Literature Finder
Records 1 - 12 (of 12 Records) |
Query Trace: Atrial Fibrillation and CYP4F2[original query] |
---|
Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients. Journal of human genetics 2012 Oct 57 (10): 665-9. Pathare Anil, Al Khabori Murtadha, Alkindi Salam, Al Zadjali Shoaib, Misquith Rhea, Khan Hammad, Lapoumeroulie Claudine, Paldi Andras, Krishnamoorthy Rajagop |
A new algorithm to predict warfarin dose from polymorphisms of CYP4F2 , CYP2C9 and VKORC1 and clinical variables: derivation in Han Chinese patients with non valvular atrial fibrillation. Thrombosis and haemostasis 2012 Jun 107 (6): 1083-91. Wei Meng, Ye Fei, Xie Dujiang, Zhu Yubing, Zhu Junrong, Tao Yifu, Yu Fe |
Prediction of stable acenocoumarol dose by a pharmacogenetic algorithm. Pharmacogenetics and genomics 2014 Oct 24 (10): 501-13. Jiménez-Varo Enrique, Cañadas-Garre Marisa, Gutiérrez-Pimentel María J, Calleja-Hernández Miguel |
[Impact of six genetic polymorphisms on Warfarin maintenance dose variation in Chinese Han population]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2014 Jun 31 (3): 367-71. Lou Ying, Han Lulu, Li Yan, Zhang Xiaoxing, Liu Zhihong, Tang Min, Yu Haiwen, Wang Wei, Xu Jianping, Liu Hong, Li Yis |
Pharmacogenetics role in the safety of acenocoumarol therapy. Thrombosis and haemostasis 2014 Sep 112 (3): 522-36. Jiménez-Varo E, Cañadas-Garre M, Henriques C I, Pinheiro A M, Gutiérrez-Pimentel M J, Calleja-Hernández M |
The impact of CYP4F2, ABCB1, and GGCX polymorphisms on bleeding episodes associated with acenocoumarol in Russian patients with atrial fibrillation. Drug metabolism and personalized therapy 2016 Sep 31 (3): 173-8. Sychev Dmitriy Alexeyevich, Rozhkov Aleksandr Vladimirovich, Kazakov Ruslan Evgenyevich, Ananichuk Anna Viktorov |
The rs2108622 polymorphism is related to the early risk of ischemic stroke in non-valvular atrial fibrillation subjects under oral anticoagulation. The pharmacogenomics journal 2017 Dec . Colàs-Campàs L, Royo J L, Montserrat M V, Marzo C, Molina-Seguín J, Benabdelhak I, Cambray S, Purroy |
Clinical and genetic factors influencing acenocoumarol dosing: a cross-sectional study. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2018 6 29 (6): 496-500. Vázquez Carolina, Orlova María, Scibona Paula, Ferreyro Bruno L, Otero Victoria, Jáuregui Esteban G, Arbelbide Jorge, Belloso Waldo |
Impact of VKORC1, CYP4F2 and NQO1 gene variants on warfarin dose requirement in Han Chinese patients with catheter ablation for atrial fibrillation. BMC cardiovascular disorders 2018 May 18 (1): 96. Li Jiao, Yang Wenlong, Xie Zhonghui, Yu Kun, Chen Yuhua, Cui Kaij |
Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial. European journal of clinical pharmacology 2018 2 74 (5): 571-582. Zambon Carlo Federico, Pengo Vittorio, Moz Stefania, Bozzato Dania, Fogar Paola, Padoan Andrea, Plebani Mario, Groppa Francesca, De Rosa Giovanni, Padrini Rober |
CYP4F2 and VKORC1 Polymorphisms Amplify the Risk of Carotid Plaque Formation. Genes 2020 7 11 (7): . Vesa Stefan Cristian, Vlaicu Sonia Irina, Vacaras Vitalie, Crisan Sorin, Sabin Octavia, Pasca Sergiu, Trifa Adrian Pavel, Rusz-Fogarasi Tamas, Sava Madalina, Buzoianu Anca Da |
Influence of Clinically Significant Genes on Antiplatelet Effect of Clopidogrel and Clinical Outcomes in Patients with Acute Coronary Syndrome and Atrial Fibrillation. Pharmacology 2022 Jan 1-11. Baturina Olga, Andreev Denis, Fedina Ludmila, Mirzaev Karin, Ivashchenko Dmitriy, Ryzhikova Kristina, Grishina Elena, Bochkov Pavel, Shevchenko Roman, Sychev Dmitr |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: